Live Breaking News & Updates on காலாண்டு புதுப்பிப்பு மாநாடு அழைப்பு

Stay updated with breaking news from காலாண்டு புதுப்பிப்பு மாநாடு அழைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fusion Fuel Green Hosts Second Quarter 2021 Investor Update

Halozyme Reports First Quarter 2021 Results


Halozyme Reports First Quarter 2021 Results
- First Quarter Revenue of $89.0 million, Up from $25.4 million in First Quarter of 2020 -
- Record Quarterly Royalties in the First Quarter of $36.9 million Representing 119% Growth over First Quarter 2020 -
- Reiterate 2021 Revenue Guidance of $375 Million to $395 Million Representing 40% to 48% Growth over 2020 Revenue -
- Reiterate 2021 GAAP Operating Income Guidance of $215 million to $235 million, Representing 49%-63% Growth over 2020 GAAP Operating Income -
News provided by
Share this article
Share this article
SAN DIEGO, May 10, 2021 /PRNewswire/  Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the first quarter ended March 31, 2021 and provided an update on its recent corporate activities and outlook. ....

San Diego , United States , Al Kildani , Helen Torley , Bristol Myers Squibb , Janssen Biotech Inc , Drug Administration , Janssen Pharmaceutical Companies Of Johnson , Halozyme Therapeutics Inc , Exchange Commission , Japan Ministry Of Health , Corporate Communications , Health Canada , Halozyme Therapeutics , Partner Highlights , Janssen Pharmaceutical Companies , Myers Squibb , Corporate Highlights , Senior Notes , Full Year , Quarterly Update Conference Call , Regarding Use , Annual Report , Investor Relations , Consolidated Statements , சான் டியாகோ ,

Halozyme To Host First Quarter 2021 Financial Results Webcast And Conference Call


Halozyme To Host First Quarter 2021 Financial Results Webcast And Conference Call
News provided by
Share this article
Share this article
SAN DIEGO, April 20, 2021 /PRNewswire/  Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2021 on Monday, May 10 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date, Halozyme will release financial results for the first quarter ended March 31, 2021 following the close of trading.
To register for this conference call, please use this link: http://www.directeventreg.com/registration/event/1584694. After registering, you will receive an email confirmation that includes dial in details and unique conference call codes for entry. Registration is open through the live call. However, to ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes b ....

San Diego , United States , Al Kildani , Helen Torley , Bristol Myers Squibb , Corporate Communications , Halozyme Therapeutics Inc , Halozyme Therapeutics , Quarterly Update Conference Call , Investor Relations , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , பெருநிறுவன தகவல்தொடர்புகள் , காலாண்டு புதுப்பிப்பு மாநாடு அழைப்பு , முதலீட்டாளர் உறவுகள் ,